Oakland, Calif.-based Kaiser Permanente Ventures has a large venture capital arm making a diverse array of investments from digital health companies to plant-based tube feeding companies.
Here are four investments from Kaiser Permanente Ventures:
- Kaiser Permanente Ventures joined in a $75 million series C funding round for the digital patient booking platform DexCare.
- The health system's venture capital arm participated with Cigna in a $34 million round for NOCD, a company that offers virtual care for obsessive-compulsive disorder.
- In November 2022, Kaiser led a $12 million funding round for remote care company Validic.
- In September 2022, Kaiser joined in on a $75 million funding round for Kate Farms, which produces plant-based nutritional products for tube or oral feeding.